GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
GE HealthCare Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$69.76+0.19 (+0.27%)
Close on Oct 19, 2026
- Market cap
- $31.67B
- P/E (TTM)
- 16.0
- Dividend yield
- 0.20%
GE HealthCare Technologies Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Imaging | $9.25B | $8.86B | $8.94B | $8.40B | $9.43B | 44.8% | +4.4% |
| AVS | $5.35B | $5.13B | $5.09B | $5.01B | – | 26.0% | +4.3% |
| PCS | $3.09B | $3.13B | $3.14B | $2.92B | $2.92B | 15.0% | -1.2% |
| PDx | $2.90B | $2.51B | $2.31B | $1.96B | $2.02B | 14.1% | +15.6% |
| Ultrasound | – | – | $3.46B | $3.42B | $3.17B | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Product | $13.66B | $13.08B | $13.13B | $12.04B | $11.17B | 66.2% | +4.5% |
| Service | $6.96B | $6.60B | $6.43B | $6.30B | $6.42B | 33.8% | +5.6% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| All other countries | $9.43B | $8.92B | $8.76B | $8.20B | $8.02B | 45.7% | +5.7% |
| United States | $9.17B | $8.62B | $8.23B | $7.82B | $7.06B | 44.5% | +6.4% |
| China | $2.03B | $2.14B | $2.56B | $2.33B | $2.51B | 9.8% | -4.9% |
From the segment and revenue-disaggregation notes of GE HealthCare Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.